{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Know Labs, Inc. Common Stock"},"Symbol":{"label":"Symbol","value":"KNW"},"Address":{"label":"Address","value":"500 UNION STREET,SUITE 810 SUITE 810, SEATTLE, Washington, 98101, United States"},"Phone":{"label":"Phone","value":"+1 206 903-1351"},"Industry":{"label":"Industry","value":null},"Sector":{"label":"Sector","value":null},"Region":{"label":"Region","value":null},"CompanyDescription":{"label":"Company Description","value":"Know Labs Inc is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the unique signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or micro needles."},"CompanyUrl":{"label":"Company Url","value":null},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Dominic Klyve","title":"Chief Science Officer"},{"name":"James H. Anderson","title":"Chief Medical Officer"},{"name":"Ronald Peter Erickson","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}